Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CSL Behring
CSL Behring Solicits Proposals for LEAD Grants to Support Patient Advocacy Efforts
October 18th, 2008
CSL Behring, a global leader in the plasma protein biotherapeutics industry, is soliciting grants to support patient access to care through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program is committed to funding grassroots advocacy efforts in the United States by providing grants to patient organizations dedicated to helping people with rare diseases who use plasma-derived or recombinant therapies to manage their conditions. "CSL Behring is proud to support patient organizations in their advocacy initiatives through LEAD grants," said Dennis Jackman, Senior Vice President, Public Affairs. "CSL Behring LEAD grants supplement existing...
Source: Law & Health Weekly (2008-10-18)
|
